BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9973213)

  • 1. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.
    Benedetti S; Bruzzone MG; Pollo B; DiMeco F; Magrassi L; Pirola B; Cirenei N; Colombo MP; Finocchiaro G
    Cancer Res; 1999 Feb; 59(3):645-52. PubMed ID: 9973213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
    Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas.
    Benedetti S; Pirola B; Poliani PL; Cajola L; Pollo B; Bagnati R; Magrassi L; Tunici P; Finocchiaro G
    Gene Ther; 2003 Jan; 10(2):188-92. PubMed ID: 12571648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
    Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
    Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
    Okada H; Giezeman-Smits KM; Tahara H; Attanucci J; Fellows WK; Lotze MT; Chambers WH; Bozik ME
    Gene Ther; 1999 Feb; 6(2):219-26. PubMed ID: 10435106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
    Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer.
    Saleh M; Jonas NK; Wiegmans A; Stylli SS
    Gene Ther; 2000 Oct; 7(20):1715-24. PubMed ID: 11083492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
    Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H
    Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of tumor immunogenicity of rat glioma cells by s-Myc expression: eradication of rat gliomas in vivo.
    Asai A; Miyagi Y; Hashimoto H; Lee SH; Mishima K; Sugiyama A; Tanaka H; Mochizuki T; Yasuda T; Kuchino Y
    Cell Growth Differ; 1994 Nov; 5(11):1153-8. PubMed ID: 7848917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.
    Saleh M; Wiegmans A; Malone Q; Stylli SS; Kaye AH
    J Natl Cancer Inst; 1999 Mar; 91(5):438-45. PubMed ID: 10070943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats.
    Iwadate Y; Inoue M; Saegusa T; Tokusumi Y; Kinoh H; Hasegawa M; Tagawa M; Yamaura A; Shimada H
    Clin Cancer Res; 2005 May; 11(10):3821-7. PubMed ID: 15897582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
    Tjuvajev J; Gansbacher B; Desai R; Beattie B; Kaplitt M; Matei C; Koutcher J; Gilboa E; Blasberg R
    Cancer Res; 1995 May; 55(9):1902-10. PubMed ID: 7728757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.